Biopharmaceutical RFP Flow, Characteristics and Outlook

Published October 2014, 57 pages

This September 2014 study examines perceptions of 133 decision makers within large, mid–size and small pharmaceutical and biotechnology companies in North America and Europe on trends in the number, size, pricing, scope and therapeutic area(s) of interest of new RFPs/proposals sent to CROs for outsourced preclinical & clinical development work, key drivers of RFP volume and timing, and expected outlook of RFP volume within key preclinical and clinical development areas. The report is an update of the 2009 report.

Biopharmaceutical RFP Flow, Characteristics and Outlook
Click To Enlarge
  • Item #: 0012
  * Marked fields are required.
Qty*
Price $399.00